A-Alpha Bio, Inc. — Form D
A-Alpha Bio, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-08. The offering totals $20.3M, of which $20.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-09-08
- Form: D
- Accession: 0001881211-21-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $20.3M
- Amount sold: $20.3M
- Investors: 18
- Date of first sale: 2021-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412668
Issuer
- Name: A-Alpha Bio, Inc.
- CIK: 0001789664
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 4000 MASON ROAD, SEATTLE, WA, 98195
- Phone: 206-890-9704
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ben Askew | Director | Bethesda, MD |
| Randolph Lopez Barrezueta | Director | SEATTLE, WA |
| Matt McIlwain | Director | Bellevue, WA |
| David Younger | Director | SEATTLE, WA |
| David Younger | Executive Officer | SEATTLE, WA |
| David Younger | Promoter | SEATTLE, WA |
Other filings by this issuer (1)
More